tokens: BACKGROUND : Several studies have demonstrated liposomal doxorubicin ( Doxil ) to be an active antineoplastic agent in platinum - resistant ovarian cancer , with dose limiting toxicity of the standard dosing regimen ( 50 mg / m ( 2 ) q 4 weeks ) being severe erythrodysesthesia ( " hand - foot syndrome " ) and stomatitis .